Avantor, Inc. (NYSE:AVTR) Shares Acquired by Castleview Partners LLC

Castleview Partners LLC lifted its stake in shares of Avantor, Inc. (NYSE:AVTR) by 35.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,514 shares of the company’s stock after purchasing an additional 4,599 shares during the quarter. Castleview Partners LLC’s holdings in Avantor were worth $453,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Versant Capital Management Inc raised its holdings in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. lifted its holdings in Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after acquiring an additional 1,391 shares during the period. UMB Bank n.a. purchased a new stake in Avantor during the third quarter worth about $49,000. GAMMA Investing LLC grew its position in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after buying an additional 1,285 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in Avantor in the first quarter valued at about $93,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AVTR has been the subject of several research reports. Barclays lifted their price objective on Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Morgan Stanley upped their target price on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Stifel Nicolaus raised their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Robert W. Baird boosted their target price on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Finally, Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $30.00 to $23.00 in a report on Wednesday, July 10th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.00.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.50% of the company’s stock.

Avantor Price Performance

Shares of AVTR traded down $0.28 during midday trading on Monday, reaching $24.45. The stock had a trading volume of 1,377,631 shares, compared to its average volume of 6,408,137. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company has a market capitalization of $16.61 billion, a P/E ratio of 63.41, a P/E/G ratio of 2.93 and a beta of 1.33. The firm’s 50 day moving average price is $25.65 and its 200-day moving average price is $24.33. Avantor, Inc. has a 52 week low of $16.63 and a 52 week high of $28.00.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. On average, analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.